Geron financials
WebGeron Corporation Common Stock (GERN) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets. WebWuchan Zhongda Geron Co.,Ltd. announced on 12 April 2024 the final profit distribution proposal for 2024 as Cash dividend/10 shares : CNY 1.10000000.... April 13, 2024 ... Financials . Sales 2024: 2 836 M 412 M 412 M: Net income 2024: 104 M 15,1 M 15,1 M: Net Debt 2024: 136 M 19,7 M 19,7 M: P/E ratio 2024: 22,2x: Yield 2024-Capitalization:
Geron financials
Did you know?
WebJun 22, 2024 · Geron's market cap is currently ―. The company's EPS TTM is $-0.366; its P/E ratio is -5.60; Geron is scheduled to report earnings on May 8, 2024, and the … WebMar 27, 2024 · Detailed financial statements for Geron (GERN), including the income statement, balance sheet, and cash flow statement. ... Source: Financials are provided …
Web20 hours ago · Financials Financial Overview ; Income Statements ; Balance Sheet ; Cash flow Statements ... Geron (GERN) Receives a New Rating from Goldman Sachs 03/28/23-5:26AM EST TipRanks WebComplete Geron Corp. stock information by Barron's. View real-time GERN stock price and news, along with industry-best analysis.
WebGeron Corporation Reports Fourth Quarter and Full-Year 2024 Financial Results and Upcoming Milestones. Learn more. Geron Announces Positive Top-Line Results from … WebAug 11, 2024 · For the second quarter of 2024, the Company reported a net loss of $28.1 million, or $0.07 per share, compared to $29.6 million, or $0.09 per share, for the comparable 2024 period. Net loss for the first six months of 2024 was $58.2 million, or $0.16 per share, compared to $57.4 million, or $0.18 per share, for the comparable 2024 period.
WebMar 3, 2015 · Organizational Resizing Also Announced Conference Call Scheduled for 4:30 p.m. EST Today, March 3 MENLO PARK, Calif., March 3, 2015 -- Geron Corporation (Nasdaq: GERN) today reported financial ...
WebMay 10, 2024 · FOSTER CITY, Calif.--(BUSINESS WIRE)-- Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, to treat hematologic myeloid malignancies, today reported financial results for the first quarter ended March 31, 2024, as well as company … philippians fourWebMar 10, 2024 · GERON CORPORATION CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED) Three Months Ended Year Ended December 31, December 31, (In thousands, except share and per share data) 2024. 2024. 2024. 2024 ... philippians four eightWeb1 day ago · Thursday, April 20 at 10:15 a.m. ET. Stifel 2024 Virtual Targeted Oncology Days. Tuesday, April 25 at 2:00 p.m. ET. A webcast of each fireside chat and corporate presentation will be available through the Investor Relations section of Geron’s website under Events. Following each scheduled conference event, the related webcast will be … philippians greek textWebMar 9, 2024 · Geron will host a conference call to discuss the financial results as well as upcoming milestones at 4:30 p.m. ET the same day. FOSTER CITY, Calif., March 09, 2024--Geron Corporation (Nasdaq: GERN ... truly aliceWebMar 27, 2024 · Detailed financial statements for Geron (GERN), including the income statement, balance sheet, and cash flow statement. ... Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual and quarterly reports submitted to the Securities and Exchange Commission (SEC). Sections ... philippians four nineteenWebJul 30, 2024 · Zacks Equity Research. Wall Street expects a year-over-year increase in earnings on higher revenues when Geron (GERN) reports results for the quarter ended June 2024. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price … truly and associatestruly amazing god john p kee